Table 1.
Patient demographics
| Factor | Overall | ||
|---|---|---|---|
| n | 349 | ||
| Age (years) | Median [IQR] | 77.0 [72.0-84.0] | |
| BMI (kg/m2) | Mean (SD) | 22.0 (3.75) | |
| (%) | <18.5 | n (%) | 59 (16.9) |
| 18.5-25 | n (%) | 222 (63.6) | |
| 25-30 | n (%) | 62 (17.8) | |
| >30 | n (%) | 6 (1.7) | |
| Anti-osteoporotic drugs | Any | n (%) | 139 (39.8) |
| SERM | n (%) | 13 (3.7) | |
| Bisphosphonate | n (%) | 87 (24.9) | |
| Denosumab | n (%) | 22 (6.3) | |
| Teriparatide | n (%) | 17 (4.9) | |
| Estimated dietary calcium intake (g) | Mean (SD) | 13.3 (5.1) | |
| BMD (mg/cm2) | Hip | Median [IQR] | 0.62 [0.53-0.69] |
| Spine | Median [IQR] | 0.78 [0.67-0.88] | |
| Previous fracture | Any | n (%) | 237 (67.9) |
| Spine | n (%) | 226 (64.8) | |
| Hip | n (%) | 20 (5.7) | |
| Pelvis | n (%) | 9 (2.6) | |
| Other extremities | n (%) | 6 (1.7) | |
| Serum calcium (mg/dL) | Mean (SD) | 9.4 (0.6) | |
| Creatinine (mg/dL) | Mean (SD) | 0.68 (0.29) | |
| eGFR (mL/min/1.73 m2) | Mean (SD) | 69.6 (20.7) | |
| 25(OH)D (ng/mL) | Mean (SD) | 15.6 (8.0) | |
| <20 | n (%) | 278 (79.8) | |
| 20-30 | n (%) | 63 (18.1) | |
| ≥30 | n (%) | 8 (2.3) | |
| History of fall | n (%) | 126 (36.3) | |
| Apprehension about fall | n (%) | 190 (54.4) | |
| Grip strength (dominant hand) (kg) | Median [IQR] | 15.7 [10.9-20.0] | |
| Fall score | Median [IQR] | 6.0 [2.0-9.0] | |
IQR interquartile range; BMI body mass index; SD standard deviation; SERM selective estrogen receptor modulator; BMD bone mineral density; eGFR estimated glomerular filtration rate; 25(OH)D 25-hydroxyvitamin D